Side Letter: What a time to have a $10bn secondaries fund

What Blackstone’s $3.45 billion portfolio acquisition says about life science; how the firm formerly known as Meyer Bergman fared with its first fund; Prologis’s outlook on logistics demand; and more in today's briefing, exclusively for our valued subscribers.